Description: For GEICAM, the future for the treatment of breast cancer implies a multidisciplinary approach, i.e. with teams of professionals in hospitals, comprising the different specialists involved in prevention, diagnosis research, and treatment: radiologists, pathologists, biologists, surgeons or gynaecologists, radiation oncologists and medical oncologists among others.
DA: 43 PA: 97 MOZ Rank: 1
Description: GEICAM T-Habla: conversamos sobre el linfedema con AEL 8 septiembre, 2020 . Coincidiendo con la celebración del Día Mundial de la Fisioterapia, hemos dedicado una nueva entrega de nuestro podcast GEICAM T-Habla al linfedema, una de las mayores complicaciones que pueden experimentar los pacientes con cáncer de mama tras someterse a una cirugía del tumor.
DA: 51 PA: 81 MOZ Rank: 65
Description: Moreover, the percentages of patients with triple-negative disease also differed in the two trials. 8,9 In the GEICAM/2003-10 trial, 12% of the patients had triple-negative disease, and no ...
DA: 99 PA: 88 MOZ Rank: 92
Description: Browse Pages. Bands, Businesses, Restaurants, Brands and Celebrities can create Pages in order to connect with their fans and customers on Facebook.
DA: 77 PA: 18 MOZ Rank: 25
Description: A total of 57 paired primary and metastatic tumours from GEICAM/2009-03 (ConvertHER, NCT01377363) study participants with centrally assessed CS (n = 57) and IS (n = 46) were analysed. Targeted capture and next-generation sequencing of 202 genes on formalin-fixed paraffin-embedded samples was performed.
DA: 24 PA: 60 MOZ Rank: 13
Description: The patient and tumor characteristics between both arms were “well balanced,” according to study presenter Miguel Martín, MD, PhD, professor of medicine and head of the Medical Oncology ...
DA: 15 PA: 55 MOZ Rank: 61
Description: The GEICAM/2003-11_CIBOMA/2004-01 trial explored extended adjuvant capecitabine after completion of standard chemotherapy in patients with early TNBC. Patients and methods: Eligible patients were those with operable, node-positive-or node negative with tumor 1 cm or greater-TNBC, with prior anthracycline- and/or taxane-containing chemotherapy.
DA: 57 PA: 60 MOZ Rank: 34
Description: The GEICAM/2006-10 trial was designed to see whether achieving a complete estrogen blockade with an AI, minimizing serum estradiol levels, and using the SERD fulvestrant to prevent activation of tumor estrogen receptors could prove a more effective treatment strategy than endocrine therapy with an AI alone, Dr. Ruíz-Borrego explained.
DA: 60 PA: 51 MOZ Rank: 36
Description: The GEICAM 9805 trial showed that in women with operable, high-risk, node-negative, early-stage breast cancer, adjuvant TAC significantly improved disease-free survival (the primary end point) as ...
DA: 5 PA: 82 MOZ Rank: 37
Description: Skip to main content … RDC Onsite: Help
DA: 72 PA: 78 MOZ Rank: 34